Company Filing History:
Years Active: 2018-2023
Title: Stepan Havel: Innovator in Nuclease Inhibition
Introduction
Stepan Havel is a notable inventor based in Cernozice, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit nucleases. With a total of 3 patents to his name, Havel's work is paving the way for advancements in medical treatments.
Latest Patents
Havel's latest patents include innovative compounds that serve as inhibitors of nucleases. The first patent, titled "Substituted aminothiazoles as inhibitors of nucleases," describes compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, and R6 are identified as inhibitors of nucleases. These compounds are particularly useful in methods for treating and preventing proliferative diseases, neurodegenerative diseases, and other genomic instability-associated diseases. The second patent, "Substituted propanamides as inhibitors of nucleases," similarly outlines compounds that inhibit nucleases and are beneficial in treating the same range of diseases.
Career Highlights
Havel is affiliated with Masaryk University, where he conducts research and develops his innovative compounds. His work is characterized by a strong focus on addressing critical health issues through biochemical research.
Collaborations
Some of Havel's notable coworkers include Kamil Paruch and Benoit Carbain, who contribute to his research efforts and collaborative projects.
Conclusion
Stepan Havel's contributions to the field of nuclease inhibition are significant and impactful. His innovative patents and collaborative work at Masaryk University highlight his dedication to advancing medical science.